NeoGenomics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. 

CEO
Anthony P. Zook
CEOAnthony P. Zook
Employees
2,200
Employees2,200
Headquarters
Fort Myers, Florida
HeadquartersFort Myers, Florida
Founded
1998
Founded1998
Employees
2,200
Employees2,200

NEO Key Statistics

Market cap
1.47B
Market cap1.47B
Price-Earnings ratio
-12.82
Price-Earnings ratio-12.82
Dividend yield
Dividend yield
Average volume
1.53M
Average volume1.53M
High today
$11.61
High today$11.61
Low today
$11.17
Low today$11.17
Open price
$11.33
Open price$11.33
Volume
2.61M
Volume2.61M
52 Week high
$14.73
52 Week high$14.73
52 Week low
$4.72
52 Week low$4.72

Stock Snapshot

The current NeoGenomics(NEO) stock price is $11.38, with a market capitalization of 1.47B. The stock trades at a price-to-earnings (P/E) ratio of -12.82.

During the trading session on 2026-02-14, NeoGenomics(NEO) shares reached a daily high of $11.61 and a low of $11.17. At a current price of $11.38, the stock is +1.9% higher than the low and still -2.0% under the high.

Trading activity shows a volume of 2.61M, compared to an average daily volume of 1.53M.

Over the past 52 weeks, NeoGenomics(NEO) stock has traded between a high of $14.73 and a low of $4.72.

Over the past 52 weeks, NeoGenomics(NEO) stock has traded between a high of $14.73 and a low of $4.72.

NEO News

Simply Wall St 11h
A Look At NeoGenomics Valuation After The Launch Of PanTracer Pro In Precision Oncology

NeoGenomics (NEO) has launched PanTracer Pro, a new molecular testing solution that combines comprehensive genomic profiling with diagnosis-directed assays for...

A Look At NeoGenomics Valuation After The Launch Of PanTracer Pro In Precision Oncology

Analyst ratings

50%

of 14 ratings
Buy
42.9%
Hold
50%
Sell
7.1%

People also own

Based on the portfolios of people who own NEO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.